Article
29 Sep 2025
FDA's Latest On Emergency Diagnostics And A No-Frills Rescission Of The LDT Rule
AUTHORS CONTENT
Article
22 Jul 2025
FDA Announces AI Councils Amid Calls For Greater Agency Transparency
Article
15 Jul 2025
FDA Opens The Vault On Decision Letters—Releases Wave Of Drug And Biologic CRLs
Article
01 Jul 2025
HHS To Launch Campaign Promoting Wearable Devices
Article
09 Jun 2025
No Appeal Of LDT Decision Means Ball Is Back In FDA's Court For Policy Clarification
Article
04 Jun 2025
Five FDA Takeaways From The FY26 Budget
Article
05 Apr 2025
District Court Vacates FDA LDT Rule; What's Next For Regulation Of Lab Testing?
Article
14 Mar 2025
Is Self-Affirming GRAS Off The Menu?
Article
10 Jan 2025
FDA Announces Draft Guidance On Accelerated Approval And Considerations For Determining Whether A Confirmatory Trial Is Underway
Article
10 Dec 2024
FDA Announces Draft Guidance For Industry Regarding Accelerated Approval For Drugs And Biologics
Article
13 Nov 2024
FDA Approves The First Flu Vaccine For At Home Use, Providing A Needle Free Option Outside Of Traditional Health Care Settings
Article
11 Jul 2024
Chevron Runs Out Of Gas: The Bumpy Road Ahead For Health Regulations After Loper Bright
Article
03 Jun 2024
High Stakes: HHS Shakes Things Up On Marijuana Scheduling And DEA Abides
Article
09 May 2024
FDA Finalizes LDT Regulation, With Significant Exceptions: Enforcement Of Requirements Will Phase In Over Four Years
Article
05 Mar 2024
Cannabis In 2024: HHS Rescheduling Recommendation And SAFER Banking
Article
03 Jan 2024
FDA Serves Up More Food For Thought: 2024 Will Be A Pivotal Year For The Agency's Reorganization Efforts
Article
04 Oct 2023
FDA's Proposed Rule On Laboratory Developed Tests: One Small Change To Regulatory Language That Would Mark A Giant Leap In Lab Testing Regulation
Article
23 Feb 2023
FTC's First-of-Its-Kind Health Breach Notification Rule Enforcement Action
Article
03 Feb 2023
Food For Thought: FDA Proposes New Vision For The Human Foods Program
Article
01 Feb 2023
FDA Harshes The CBD Buzz; Is It High Time For Congress To Step In?